Hologic Capex To Revenue from 2010 to 2025

HOLX Stock  USD 60.80  1.09  1.76%   
Hologic Capex To Revenue yearly trend continues to be fairly stable with very little volatility. Capex To Revenue is likely to outpace its year average in 2025. Capex To Revenue is the ratio of a company's capital expenditures to its total revenue, indicating how much of the revenue is used for acquiring or maintaining physical assets. View All Fundamentals
 
Capex To Revenue  
First Reported
2010-12-31
Previous Quarter
0.03726677
Current Value
0.0438
Quarterly Volatility
0.00549103
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Hologic financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Hologic's main balance sheet or income statement drivers, such as Depreciation And Amortization of 373.1 M, Interest Expense of 74.8 M or Total Revenue of 4.9 B, as well as many indicators such as Price To Sales Ratio of 2.14, Dividend Yield of 0.0 or PTB Ratio of 3.24. Hologic financial statements analysis is a perfect complement when working with Hologic Valuation or Volatility modules.
  
Check out the analysis of Hologic Correlation against competitors.
For more information on how to buy Hologic Stock please use our How to Invest in Hologic guide.

Latest Hologic's Capex To Revenue Growth Pattern

Below is the plot of the Capex To Revenue of Hologic over the last few years. It is the ratio of a company's capital expenditures to its total revenue, indicating how much of the revenue is used for acquiring or maintaining physical assets. Hologic's Capex To Revenue historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Hologic's overall financial position and show how it may be relating to other accounts over time.
Capex To Revenue10 Years Trend
Pretty Stable
   Capex To Revenue   
       Timeline  

Hologic Capex To Revenue Regression Statistics

Arithmetic Mean0.03
Geometric Mean0.03
Coefficient Of Variation17.29
Mean Deviation0
Median0.03
Standard Deviation0.01
Sample Variance0.00003
Range0.0176
R-Value0.24
Mean Square Error0.000031
R-Squared0.06
Significance0.38
Slope0.0003
Total Sum of Squares0.0005

Hologic Capex To Revenue History

2025 0.0438
2024 0.0373
2016 0.0262
2011 0.0348
2010 0.0268

About Hologic Financial Statements

Hologic investors use historical fundamental indicators, such as Hologic's Capex To Revenue, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Hologic. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Capex To Revenue 0.04  0.04 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Hologic Stock Analysis

When running Hologic's price analysis, check to measure Hologic's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Hologic is operating at the current time. Most of Hologic's value examination focuses on studying past and present price action to predict the probability of Hologic's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Hologic's price. Additionally, you may evaluate how the addition of Hologic to your portfolios can decrease your overall portfolio volatility.